Skip to Main Content

Paper Details

Long-term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome-positive leukemia resistant or intolerant to prior therapy.
Eur J Haematol
6
2021
Author NameAffiliation
Jorge CortesUniversity of Texas MD Anderson Cancer Center
Hagop KantarjianUniversity of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2